Peter Kelemen
1Patents
0h-index
4Co-inventors
19Inventor score
Filing activity: Oct 27, 2017 → Oct 27, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US12358983B2 | Combination of anti CD19 antibody with a BCL-2 inhibitor and uses thereof | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.